EMEA Inaugurated In London
The European medicines Evaluation Agency, based in Canary Whaf, Dockland, London, was inaugurated last Thursday (January 26) by UK Secretary of State for Health, Virginia Bottomley.
The agency's chairman, Strachan Heppel, said last week that as a result of the EMEA's location, some overseas-based pharmaceutical manufacturers would be establishing themselves in the UK for the first time, and other companies are considering whether to set up their headquarters in the UK.
- The European Union's new Committee for Proprietary Medicinal Products held its first meeting on January 16-17. Its chairman, Jean-Michel Alexandre, and vice-chairman, Henning Hovgaard, were elected for a term of three years.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze